COVID-19 Impact on Global Atezolizumab Market Insights, Forecast to 2026
Atezolizumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atezolizumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Atezolizumab market is segmented into
The Atezolizumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Atezolizumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Atezolizumab Market Share Analysis
Atezolizumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Atezolizumab business, the date to enter into the Atezolizumab market, Atezolizumab product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Atezolizumab market is segmented into
- Use: Single Drug
- Use: Chemotherapy Combination
- Bladder Cancer
- Lung Cancer
- Advanced Triple-negative Breast Cancer
- Head and Neck Cancer
- Urothelial Carcinoma
- Renal Cell Carcinoma
- Hepatocellular Carcinoma (HCC)
- Other
The Atezolizumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Atezolizumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Atezolizumab Market Share Analysis
Atezolizumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Atezolizumab business, the date to enter into the Atezolizumab market, Atezolizumab product introduction, recent developments, etc.
The major vendors covered:
- Genentech (Roche)
1 STUDY COVERAGE
1.1 Atezolizumab Product Introduction
1.2 Market Segments
1.3 Key Atezolizumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Atezolizumab Market Size Growth Rate by Type
1.4.2 Use: Single Drug
1.4.3 Use: Chemotherapy Combination
1.5 Market by Application
1.5.1 Global Atezolizumab Market Size Growth Rate by Application
1.5.2 Bladder Cancer
1.5.3 Lung Cancer
1.5.4 Advanced Triple-negative Breast Cancer
1.5.5 Head and Neck Cancer
1.5.6 Urothelial Carcinoma
1.5.7 Renal Cell Carcinoma
1.5.8 Hepatocellular Carcinoma (HCC)
1.5.9 Other
1.6 Coronavirus Disease 2019 (Covid-19): Atezolizumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Atezolizumab Industry
1.6.1.1 Atezolizumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Atezolizumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Atezolizumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Atezolizumab Market Size Estimates and Forecasts
2.1.1 Global Atezolizumab Revenue 2015-2026
2.1.2 Global Atezolizumab Sales 2015-2026
2.2 Atezolizumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Atezolizumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Atezolizumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ATEZOLIZUMAB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Atezolizumab Sales by Manufacturers
3.1.1 Atezolizumab Sales by Manufacturers (2015-2020)
3.1.2 Atezolizumab Sales Market Share by Manufacturers (2015-2020)
3.2 Atezolizumab Revenue by Manufacturers
3.2.1 Atezolizumab Revenue by Manufacturers (2015-2020)
3.2.2 Atezolizumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Atezolizumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Atezolizumab Revenue in 2019
3.2.5 Global Atezolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Atezolizumab Price by Manufacturers
3.4 Atezolizumab Manufacturing Base Distribution, Product Types
3.4.1 Atezolizumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atezolizumab Product Type
3.4.3 Date of International Manufacturers Enter into Atezolizumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Atezolizumab Market Size by Type (2015-2020)
4.1.1 Global Atezolizumab Sales by Type (2015-2020)
4.1.2 Global Atezolizumab Revenue by Type (2015-2020)
4.1.3 Atezolizumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Atezolizumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Atezolizumab Sales Forecast by Type (2021-2026)
4.2.2 Global Atezolizumab Revenue Forecast by Type (2021-2026)
4.2.3 Atezolizumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Atezolizumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Atezolizumab Market Size by Application (2015-2020)
5.1.1 Global Atezolizumab Sales by Application (2015-2020)
5.1.2 Global Atezolizumab Revenue by Application (2015-2020)
5.1.3 Atezolizumab Price by Application (2015-2020)
5.2 Atezolizumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Atezolizumab Sales Forecast by Application (2021-2026)
5.2.2 Global Atezolizumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Atezolizumab Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Atezolizumab by Country
6.1.1 North America Atezolizumab Sales by Country
6.1.2 North America Atezolizumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Atezolizumab Market Facts & Figures by Type
6.3 North America Atezolizumab Market Facts & Figures by Application
7 EUROPE
7.1 Europe Atezolizumab by Country
7.1.1 Europe Atezolizumab Sales by Country
7.1.2 Europe Atezolizumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Atezolizumab Market Facts & Figures by Type
7.3 Europe Atezolizumab Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Atezolizumab by Region
8.1.1 Asia Pacific Atezolizumab Sales by Region
8.1.2 Asia Pacific Atezolizumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Atezolizumab Market Facts & Figures by Type
8.3 Asia Pacific Atezolizumab Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Atezolizumab by Country
9.1.1 Latin America Atezolizumab Sales by Country
9.1.2 Latin America Atezolizumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Atezolizumab Market Facts & Figures by Type
9.3 Central & South America Atezolizumab Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Atezolizumab by Country
10.1.1 Middle East and Africa Atezolizumab Sales by Country
10.1.2 Middle East and Africa Atezolizumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Atezolizumab Market Facts & Figures by Type
10.3 Middle East and Africa Atezolizumab Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Atezolizumab Products Offered
11.1.5 Genentech (Roche) Recent Development
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Atezolizumab Products Offered
11.1.5 Genentech (Roche) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Atezolizumab Market Estimates and Projections by Region
12.1.1 Global Atezolizumab Sales Forecast by Regions 2021-2026
12.1.2 Global Atezolizumab Revenue Forecast by Regions 2021-2026
12.2 North America Atezolizumab Market Size Forecast (2021-2026)
12.2.1 North America: Atezolizumab Sales Forecast (2021-2026)
12.2.2 North America: Atezolizumab Revenue Forecast (2021-2026)
12.2.3 North America: Atezolizumab Market Size Forecast by Country (2021-2026)
12.3 Europe Atezolizumab Market Size Forecast (2021-2026)
12.3.1 Europe: Atezolizumab Sales Forecast (2021-2026)
12.3.2 Europe: Atezolizumab Revenue Forecast (2021-2026)
12.3.3 Europe: Atezolizumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Atezolizumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Atezolizumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Atezolizumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Atezolizumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Atezolizumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Atezolizumab Sales Forecast (2021-2026)
12.5.2 Latin America: Atezolizumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Atezolizumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Atezolizumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Atezolizumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Atezolizumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Atezolizumab Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Atezolizumab Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Atezolizumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Atezolizumab Product Introduction
1.2 Market Segments
1.3 Key Atezolizumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Atezolizumab Market Size Growth Rate by Type
1.4.2 Use: Single Drug
1.4.3 Use: Chemotherapy Combination
1.5 Market by Application
1.5.1 Global Atezolizumab Market Size Growth Rate by Application
1.5.2 Bladder Cancer
1.5.3 Lung Cancer
1.5.4 Advanced Triple-negative Breast Cancer
1.5.5 Head and Neck Cancer
1.5.6 Urothelial Carcinoma
1.5.7 Renal Cell Carcinoma
1.5.8 Hepatocellular Carcinoma (HCC)
1.5.9 Other
1.6 Coronavirus Disease 2019 (Covid-19): Atezolizumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Atezolizumab Industry
1.6.1.1 Atezolizumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Atezolizumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Atezolizumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Atezolizumab Market Size Estimates and Forecasts
2.1.1 Global Atezolizumab Revenue 2015-2026
2.1.2 Global Atezolizumab Sales 2015-2026
2.2 Atezolizumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Atezolizumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Atezolizumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ATEZOLIZUMAB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Atezolizumab Sales by Manufacturers
3.1.1 Atezolizumab Sales by Manufacturers (2015-2020)
3.1.2 Atezolizumab Sales Market Share by Manufacturers (2015-2020)
3.2 Atezolizumab Revenue by Manufacturers
3.2.1 Atezolizumab Revenue by Manufacturers (2015-2020)
3.2.2 Atezolizumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Atezolizumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Atezolizumab Revenue in 2019
3.2.5 Global Atezolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Atezolizumab Price by Manufacturers
3.4 Atezolizumab Manufacturing Base Distribution, Product Types
3.4.1 Atezolizumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atezolizumab Product Type
3.4.3 Date of International Manufacturers Enter into Atezolizumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Atezolizumab Market Size by Type (2015-2020)
4.1.1 Global Atezolizumab Sales by Type (2015-2020)
4.1.2 Global Atezolizumab Revenue by Type (2015-2020)
4.1.3 Atezolizumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Atezolizumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Atezolizumab Sales Forecast by Type (2021-2026)
4.2.2 Global Atezolizumab Revenue Forecast by Type (2021-2026)
4.2.3 Atezolizumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Atezolizumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Atezolizumab Market Size by Application (2015-2020)
5.1.1 Global Atezolizumab Sales by Application (2015-2020)
5.1.2 Global Atezolizumab Revenue by Application (2015-2020)
5.1.3 Atezolizumab Price by Application (2015-2020)
5.2 Atezolizumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Atezolizumab Sales Forecast by Application (2021-2026)
5.2.2 Global Atezolizumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Atezolizumab Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Atezolizumab by Country
6.1.1 North America Atezolizumab Sales by Country
6.1.2 North America Atezolizumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Atezolizumab Market Facts & Figures by Type
6.3 North America Atezolizumab Market Facts & Figures by Application
7 EUROPE
7.1 Europe Atezolizumab by Country
7.1.1 Europe Atezolizumab Sales by Country
7.1.2 Europe Atezolizumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Atezolizumab Market Facts & Figures by Type
7.3 Europe Atezolizumab Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Atezolizumab by Region
8.1.1 Asia Pacific Atezolizumab Sales by Region
8.1.2 Asia Pacific Atezolizumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Atezolizumab Market Facts & Figures by Type
8.3 Asia Pacific Atezolizumab Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Atezolizumab by Country
9.1.1 Latin America Atezolizumab Sales by Country
9.1.2 Latin America Atezolizumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Atezolizumab Market Facts & Figures by Type
9.3 Central & South America Atezolizumab Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Atezolizumab by Country
10.1.1 Middle East and Africa Atezolizumab Sales by Country
10.1.2 Middle East and Africa Atezolizumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Atezolizumab Market Facts & Figures by Type
10.3 Middle East and Africa Atezolizumab Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Atezolizumab Products Offered
11.1.5 Genentech (Roche) Recent Development
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Corporation Information
11.1.2 Genentech (Roche) Description, Business Overview and Total Revenue
11.1.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech (Roche) Atezolizumab Products Offered
11.1.5 Genentech (Roche) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Atezolizumab Market Estimates and Projections by Region
12.1.1 Global Atezolizumab Sales Forecast by Regions 2021-2026
12.1.2 Global Atezolizumab Revenue Forecast by Regions 2021-2026
12.2 North America Atezolizumab Market Size Forecast (2021-2026)
12.2.1 North America: Atezolizumab Sales Forecast (2021-2026)
12.2.2 North America: Atezolizumab Revenue Forecast (2021-2026)
12.2.3 North America: Atezolizumab Market Size Forecast by Country (2021-2026)
12.3 Europe Atezolizumab Market Size Forecast (2021-2026)
12.3.1 Europe: Atezolizumab Sales Forecast (2021-2026)
12.3.2 Europe: Atezolizumab Revenue Forecast (2021-2026)
12.3.3 Europe: Atezolizumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Atezolizumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Atezolizumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Atezolizumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Atezolizumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Atezolizumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Atezolizumab Sales Forecast (2021-2026)
12.5.2 Latin America: Atezolizumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Atezolizumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Atezolizumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Atezolizumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Atezolizumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Atezolizumab Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Atezolizumab Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Atezolizumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Atezolizumab Market Segments
Table 2. Ranking of Global Top Atezolizumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Atezolizumab Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Use: Single Drug
Table 5. Major Manufacturers of Use: Chemotherapy Combination
Table 6. COVID-19 Impact Global Market: (Four Atezolizumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Atezolizumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Atezolizumab Players to Combat Covid-19 Impact
Table 11. Global Atezolizumab Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Atezolizumab Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Atezolizumab Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Atezolizumab Sales Market Share by Regions (2015-2020)
Table 15. Global Atezolizumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Atezolizumab Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Atezolizumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Atezolizumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Atezolizumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atezolizumab as of 2019)
Table 20. Atezolizumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Atezolizumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Atezolizumab Price (2015-2020) (USD/Pcs)
Table 23. Atezolizumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Atezolizumab Product Type
Table 25. Date of International Manufacturers Enter into Atezolizumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 28. Global Atezolizumab Sales Share by Type (2015-2020)
Table 29. Global Atezolizumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Atezolizumab Revenue Share by Type (2015-2020)
Table 31. Atezolizumab Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 33. Global Atezolizumab Sales Share by Application (2015-2020)
Table 34. North America Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 35. North America Atezolizumab Sales Market Share by Country (2015-2020)
Table 36. North America Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Atezolizumab Revenue Market Share by Country (2015-2020)
Table 38. North America Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 39. North America Atezolizumab Sales Market Share by Type (2015-2020)
Table 40. North America Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 41. North America Atezolizumab Sales Market Share by Application (2015-2020)
Table 42. Europe Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Atezolizumab Sales Market Share by Country (2015-2020)
Table 44. Europe Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Atezolizumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Atezolizumab Sales Market Share by Type (2015-2020)
Table 48. Europe Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Atezolizumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Atezolizumab Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Atezolizumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Atezolizumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Atezolizumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Atezolizumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Atezolizumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Atezolizumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Atezolizumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Atezolizumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Atezolizumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Atezolizumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Atezolizumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Atezolizumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Atezolizumab Sales Market Share by Application (2015-2020)
Table 74. Genentech (Roche) Corporation Information
Table 75. Genentech (Roche) Description and Major Businesses
Table 76. Genentech (Roche) Atezolizumab Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Genentech (Roche) Product
Table 78. Genentech (Roche) Recent Development
Table 79. Global Atezolizumab Sales Forecast by Regions (2021-2026) (K Pcs)
Table 80. Global Atezolizumab Sales Market Share Forecast by Regions (2021-2026)
Table 81. Global Atezolizumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 82. Global Atezolizumab Revenue Market Share Forecast by Regions (2021-2026)
Table 83. North America: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 84. North America: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 85. Europe: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 86. Europe: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 87. Asia Pacific: Atezolizumab Sales Forecast by Region (2021-2026) (K Pcs)
Table 88. Asia Pacific: Atezolizumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Latin America: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 90. Latin America: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Middle East and Africa: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. Middle East and Africa: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Market Risks
Table 96. Main Points Interviewed from Key Atezolizumab Players
Table 97. Atezolizumab Customers List
Table 98. Atezolizumab Distributors List
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 1. Atezolizumab Market Segments
Table 2. Ranking of Global Top Atezolizumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Atezolizumab Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Use: Single Drug
Table 5. Major Manufacturers of Use: Chemotherapy Combination
Table 6. COVID-19 Impact Global Market: (Four Atezolizumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Atezolizumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Atezolizumab Players to Combat Covid-19 Impact
Table 11. Global Atezolizumab Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Atezolizumab Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Atezolizumab Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Atezolizumab Sales Market Share by Regions (2015-2020)
Table 15. Global Atezolizumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Atezolizumab Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Atezolizumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Atezolizumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Atezolizumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atezolizumab as of 2019)
Table 20. Atezolizumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Atezolizumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Atezolizumab Price (2015-2020) (USD/Pcs)
Table 23. Atezolizumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Atezolizumab Product Type
Table 25. Date of International Manufacturers Enter into Atezolizumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 28. Global Atezolizumab Sales Share by Type (2015-2020)
Table 29. Global Atezolizumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Atezolizumab Revenue Share by Type (2015-2020)
Table 31. Atezolizumab Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 33. Global Atezolizumab Sales Share by Application (2015-2020)
Table 34. North America Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 35. North America Atezolizumab Sales Market Share by Country (2015-2020)
Table 36. North America Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Atezolizumab Revenue Market Share by Country (2015-2020)
Table 38. North America Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 39. North America Atezolizumab Sales Market Share by Type (2015-2020)
Table 40. North America Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 41. North America Atezolizumab Sales Market Share by Application (2015-2020)
Table 42. Europe Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Atezolizumab Sales Market Share by Country (2015-2020)
Table 44. Europe Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Atezolizumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Atezolizumab Sales Market Share by Type (2015-2020)
Table 48. Europe Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Atezolizumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Atezolizumab Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Atezolizumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Atezolizumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Atezolizumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Atezolizumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Atezolizumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Atezolizumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Atezolizumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Atezolizumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Atezolizumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Atezolizumab Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Atezolizumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Atezolizumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Atezolizumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Atezolizumab Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Atezolizumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Atezolizumab Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Atezolizumab Sales Market Share by Application (2015-2020)
Table 74. Genentech (Roche) Corporation Information
Table 75. Genentech (Roche) Description and Major Businesses
Table 76. Genentech (Roche) Atezolizumab Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Genentech (Roche) Product
Table 78. Genentech (Roche) Recent Development
Table 79. Global Atezolizumab Sales Forecast by Regions (2021-2026) (K Pcs)
Table 80. Global Atezolizumab Sales Market Share Forecast by Regions (2021-2026)
Table 81. Global Atezolizumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 82. Global Atezolizumab Revenue Market Share Forecast by Regions (2021-2026)
Table 83. North America: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 84. North America: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 85. Europe: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 86. Europe: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 87. Asia Pacific: Atezolizumab Sales Forecast by Region (2021-2026) (K Pcs)
Table 88. Asia Pacific: Atezolizumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 89. Latin America: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 90. Latin America: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Middle East and Africa: Atezolizumab Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. Middle East and Africa: Atezolizumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Market Risks
Table 96. Main Points Interviewed from Key Atezolizumab Players
Table 97. Atezolizumab Customers List
Table 98. Atezolizumab Distributors List
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Atezolizumab Product Picture
Figure 2. Global Atezolizumab Sales Market Share by Type in 2020 & 2026
Figure 3. Use: Single Drug Product Picture
Figure 4. Use: Chemotherapy Combination Product Picture
Figure 5. Global Atezolizumab Sales Market Share by Application in 2020 & 2026
Figure 6. Bladder Cancer
Figure 7. Lung Cancer
Figure 8. Advanced Triple-negative Breast Cancer
Figure 9. Head and Neck Cancer
Figure 10. Urothelial Carcinoma
Figure 11. Renal Cell Carcinoma
Figure 12. Hepatocellular Carcinoma (HCC)
Figure 13. Other
Figure 14. Atezolizumab Report Years Considered
Figure 15. Global Atezolizumab Market Size 2015-2026 (US$ Million)
Figure 16. Global Atezolizumab Sales 2015-2026 (K Pcs)
Figure 17. Global Atezolizumab Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Atezolizumab Sales Market Share by Region (2015-2020)
Figure 19. Global Atezolizumab Sales Market Share by Region in 2019
Figure 20. Global Atezolizumab Revenue Market Share by Region (2015-2020)
Figure 21. Global Atezolizumab Revenue Market Share by Region in 2019
Figure 22. Global Atezolizumab Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Atezolizumab Revenue in 2019
Figure 24. Atezolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Atezolizumab Sales Market Share by Type (2015-2020)
Figure 26. Global Atezolizumab Sales Market Share by Type in 2019
Figure 27. Global Atezolizumab Revenue Market Share by Type (2015-2020)
Figure 28. Global Atezolizumab Revenue Market Share by Type in 2019
Figure 29. Global Atezolizumab Market Share by Price Range (2015-2020)
Figure 30. Global Atezolizumab Sales Market Share by Application (2015-2020)
Figure 31. Global Atezolizumab Sales Market Share by Application in 2019
Figure 32. Global Atezolizumab Revenue Market Share by Application (2015-2020)
Figure 33. Global Atezolizumab Revenue Market Share by Application in 2019
Figure 34. North America Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Atezolizumab Sales Market Share by Country in 2019
Figure 37. North America Atezolizumab Revenue Market Share by Country in 2019
Figure 38. U.S. Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Atezolizumab Market Share by Type in 2019
Figure 43. North America Atezolizumab Market Share by Application in 2019
Figure 44. Europe Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Atezolizumab Sales Market Share by Country in 2019
Figure 47. Europe Atezolizumab Revenue Market Share by Country in 2019
Figure 48. Germany Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Atezolizumab Market Share by Type in 2019
Figure 59. Europe Atezolizumab Market Share by Application in 2019
Figure 60. Asia Pacific Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Atezolizumab Sales Market Share by Region in 2019
Figure 63. Asia Pacific Atezolizumab Revenue Market Share by Region in 2019
Figure 64. China Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Atezolizumab Market Share by Type in 2019
Figure 87. Asia Pacific Atezolizumab Market Share by Application in 2019
Figure 88. Latin America Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Atezolizumab Sales Market Share by Country in 2019
Figure 91. Latin America Atezolizumab Revenue Market Share by Country in 2019
Figure 92. Mexico Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Atezolizumab Market Share by Type in 2019
Figure 99. Latin America Atezolizumab Market Share by Application in 2019
Figure 100. Middle East and Africa Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Atezolizumab Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Atezolizumab Revenue Market Share by Country in 2019
Figure 104. Turkey Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Atezolizumab Market Share by Type in 2019
Figure 111. Middle East and Africa Atezolizumab Market Share by Application in 2019
Figure 112. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Atezolizumab Product Picture
Figure 2. Global Atezolizumab Sales Market Share by Type in 2020 & 2026
Figure 3. Use: Single Drug Product Picture
Figure 4. Use: Chemotherapy Combination Product Picture
Figure 5. Global Atezolizumab Sales Market Share by Application in 2020 & 2026
Figure 6. Bladder Cancer
Figure 7. Lung Cancer
Figure 8. Advanced Triple-negative Breast Cancer
Figure 9. Head and Neck Cancer
Figure 10. Urothelial Carcinoma
Figure 11. Renal Cell Carcinoma
Figure 12. Hepatocellular Carcinoma (HCC)
Figure 13. Other
Figure 14. Atezolizumab Report Years Considered
Figure 15. Global Atezolizumab Market Size 2015-2026 (US$ Million)
Figure 16. Global Atezolizumab Sales 2015-2026 (K Pcs)
Figure 17. Global Atezolizumab Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Atezolizumab Sales Market Share by Region (2015-2020)
Figure 19. Global Atezolizumab Sales Market Share by Region in 2019
Figure 20. Global Atezolizumab Revenue Market Share by Region (2015-2020)
Figure 21. Global Atezolizumab Revenue Market Share by Region in 2019
Figure 22. Global Atezolizumab Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Atezolizumab Revenue in 2019
Figure 24. Atezolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Atezolizumab Sales Market Share by Type (2015-2020)
Figure 26. Global Atezolizumab Sales Market Share by Type in 2019
Figure 27. Global Atezolizumab Revenue Market Share by Type (2015-2020)
Figure 28. Global Atezolizumab Revenue Market Share by Type in 2019
Figure 29. Global Atezolizumab Market Share by Price Range (2015-2020)
Figure 30. Global Atezolizumab Sales Market Share by Application (2015-2020)
Figure 31. Global Atezolizumab Sales Market Share by Application in 2019
Figure 32. Global Atezolizumab Revenue Market Share by Application (2015-2020)
Figure 33. Global Atezolizumab Revenue Market Share by Application in 2019
Figure 34. North America Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Atezolizumab Sales Market Share by Country in 2019
Figure 37. North America Atezolizumab Revenue Market Share by Country in 2019
Figure 38. U.S. Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Atezolizumab Market Share by Type in 2019
Figure 43. North America Atezolizumab Market Share by Application in 2019
Figure 44. Europe Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Atezolizumab Sales Market Share by Country in 2019
Figure 47. Europe Atezolizumab Revenue Market Share by Country in 2019
Figure 48. Germany Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Atezolizumab Market Share by Type in 2019
Figure 59. Europe Atezolizumab Market Share by Application in 2019
Figure 60. Asia Pacific Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Atezolizumab Sales Market Share by Region in 2019
Figure 63. Asia Pacific Atezolizumab Revenue Market Share by Region in 2019
Figure 64. China Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Atezolizumab Market Share by Type in 2019
Figure 87. Asia Pacific Atezolizumab Market Share by Application in 2019
Figure 88. Latin America Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Atezolizumab Sales Market Share by Country in 2019
Figure 91. Latin America Atezolizumab Revenue Market Share by Country in 2019
Figure 92. Mexico Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Atezolizumab Market Share by Type in 2019
Figure 99. Latin America Atezolizumab Market Share by Application in 2019
Figure 100. Middle East and Africa Atezolizumab Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Atezolizumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Atezolizumab Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Atezolizumab Revenue Market Share by Country in 2019
Figure 104. Turkey Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Atezolizumab Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Atezolizumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Atezolizumab Market Share by Type in 2019
Figure 111. Middle East and Africa Atezolizumab Market Share by Application in 2019
Figure 112. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Atezolizumab Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Atezolizumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
